E25Bio

Developer of a paper-based diagnostic platform designed to effectively facilitate epidemiologic predictions and disease mapping. The company's platform offers multiplexed tests that can swiftly detect viral antigens produced during infection, results of which can be captured by a mobile phone application for real-time data reporting and analytics, enabling governments to accurately identify zika virus, dengue, and chikungunya, and novel coronavirus at the point of care at an affordable cost and effectively prevent an outbreak from turning into a public health crisis.

Khosla Ventures

🏥 Healthcare